Reports Q4 revenue $8.71M vs. $7.63M last year. “The company delivered on several actions identified when the new executive team joined in early November 2023,” said Damien Lamendola, CEO of Marpai. “We are starting to gain the benefits of the Maestro Health acquisition. We remain committed to our overall vision that Marpai Saves, through operational and financial improvements, reduces costs for our clients and improves the quality of care for our members.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRAI:
- Marpai granted extension to regain compliance
- 5 Stocks Corporate Insiders are Buying in March 2024
- MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
- Marpai announces agreement with regional organization based in the southeast
- Marpai Announces Major Financial Agreements for 2024